Russia's sovereign wealth fund has filed for registration of Sputnik V in the European Union and expects it to be reviewed in February, the official account promoting the COVID-19 vaccine tweeted on Wednesday.
The Sputnik V and European Medical Agency (EMA) teams held a scientific review of the vaccine on Tuesday, the Sputnik V account said, adding the EMA will take a decision on the authorization of the vaccine based on the reviews. (https://bit.ly/39OQZDR)
The vaccine has already been approved in Argentina, Belarus, Serbia and other countries.
Putin and Modi discuss trade, peace in New Delhi summit
Indian air travel crippled as IndiGo's pilot crisis enters fourth day
Lebanon says ceasefire talks aim primarily at halting Israel's hostilities
US to widen travel ban to more than 30 countries, Noem says
Putin visits Delhi as Russia, India seek to increase and diversify trade
